1h Free Analyst Time
The global heparin market is forecasted to grow by USD 4.10 billion during 2025-2030, accelerating at a CAGR of 7.7% during the forecast period. The report on the global heparin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of coagulation disorders, growing prevalence of chronic conditions, reintroduction of alternative sources to produce heparin.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global heparin market is segmented as below:
By Product
- Low-molecular-weight heparin
- Unfractionated heparin
- Ultra-low-molecular-weight heparin
By Route Of Administration
- Subcutaneous injection
- Intravenous infusion
By Source
- Porcine
- Bovine
- Synthetic
By Region
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- North America
- US
- Canada
- Mexico
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global heparin market covers the following areas:
- Global heparin market sizing
- Global heparin market forecast
- Global heparin market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Source
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Heparin Market 2020 - 2024
- Historic Market Size - Data Table on Global Heparin Market 2020 - 2024 ($ million)
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Source Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI in the Global Heparin Market
6.2 Impact of Geopolitical Conflicts on the Global Heparin Market
6.2 Impact of Geopolitical Conflicts on the Global Heparin Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Product
8.1 Market segments
- Chart on Product - Market share 2025-2030 (%)
- Data Table on Product - Market share 2025-2030 (%)
- Chart on Comparison by Product
- Data Table on Comparison by Product
- Chart on Low-molecular-weight heparin - Market size and forecast 2025-2030 ($ million)
- Data Table on Low-molecular-weight heparin - Market size and forecast 2025-2030 ($ million)
- Chart on Low-molecular-weight heparin - Year-over-year growth 2025-2030 (%)
- Data Table on Low-molecular-weight heparin - Year-over-year growth 2025-2030 (%)
- Chart on Unfractionated heparin - Market size and forecast 2025-2030 ($ million)
- Data Table on Unfractionated heparin - Market size and forecast 2025-2030 ($ million)
- Chart on Unfractionated heparin - Year-over-year growth 2025-2030 (%)
- Data Table on Unfractionated heparin - Year-over-year growth 2025-2030 (%)
- Chart on Ultra-low-molecular-weight heparin - Market size and forecast 2025-2030 ($ million)
- Data Table on Ultra-low-molecular-weight heparin - Market size and forecast 2025-2030 ($ million)
- Chart on Ultra-low-molecular-weight heparin - Year-over-year growth 2025-2030 (%)
- Data Table on Ultra-low-molecular-weight heparin - Year-over-year growth 2025-2030 (%)
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Route of Administration
9.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Subcutaneous injection - Market size and forecast 2025-2030 ($ million)
- Data Table on Subcutaneous injection - Market size and forecast 2025-2030 ($ million)
- Chart on Subcutaneous injection - Year-over-year growth 2025-2030 (%)
- Data Table on Subcutaneous injection - Year-over-year growth 2025-2030 (%)
- Chart on Intravenous infusion - Market size and forecast 2025-2030 ($ million)
- Data Table on Intravenous infusion - Market size and forecast 2025-2030 ($ million)
- Chart on Intravenous infusion - Year-over-year growth 2025-2030 (%)
- Data Table on Intravenous infusion - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by Source
10.1 Market segments
- Chart on Source - Market share 2025-2030 (%)
- Data Table on Source - Market share 2025-2030 (%)
- Chart on Comparison by Source
- Data Table on Comparison by Source
- Chart on Porcine - Market size and forecast 2025-2030 ($ million)
- Data Table on Porcine - Market size and forecast 2025-2030 ($ million)
- Chart on Porcine - Year-over-year growth 2025-2030 (%)
- Data Table on Porcine - Year-over-year growth 2025-2030 (%)
- Chart on Bovine - Market size and forecast 2025-2030 ($ million)
- Data Table on Bovine - Market size and forecast 2025-2030 ($ million)
- Chart on Bovine - Year-over-year growth 2025-2030 (%)
- Data Table on Bovine - Year-over-year growth 2025-2030 (%)
- Chart on Synthetic - Market size and forecast 2025-2030 ($ million)
- Data Table on Synthetic - Market size and forecast 2025-2030 ($ million)
- Chart on Synthetic - Year-over-year growth 2025-2030 (%)
- Data Table on Synthetic - Year-over-year growth 2025-2030 (%)
- Market opportunity by Source ($ million)
- Data Table on Market opportunity by Source ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Increasing prevalence of coagulation disorders
- Growing prevalence of chronic conditions
- Reintroduction of alternative sources to produce heparin
- Various side effects of heparin directly hinder its widespread adoption
- Increase in shortage of raw heparin
- Frequent product recalls are declining market demand
- Impact of drivers and challenges in 2025 and 2030
- Increasing research and development activities and new therapeutic applications of heparin
- Advent of biosimilar low-molecular-weight heparin
- Rise in funding for heparin and supply chain expansion
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- Aspen Pharmacare Ltd. - Overview
- Aspen Pharmacare Ltd. - Business segments
- Aspen Pharmacare Ltd. - Key offerings
- Aspen Pharmacare Ltd. - Segment focus
- SWOT
- B.Braun SE - Overview
- B.Braun SE - Product / Service
- B.Braun SE - Key offerings
- SWOT
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
- SWOT
- Bioiberica S.A.U. - Overview
- Bioiberica S.A.U. - Product / Service
- Bioiberica S.A.U. - Key offerings
- SWOT
- Celsus Laboratories Inc. - Overview
- Celsus Laboratories Inc. - Product / Service
- Celsus Laboratories Inc. - Key offerings
- SWOT
- CZ Pharma - Overview
- CZ Pharma - Product / Service
- CZ Pharma - Key offerings
- SWOT
- Gland Pharma Ltd - Overview
- Gland Pharma Ltd - Product / Service
- Gland Pharma Ltd - Key offerings
- SWOT
- Hepalink Group - Overview
- Hepalink Group - Product / Service
- Hepalink Group - Key offerings
- SWOT
- Hikma Pharmaceuticals Plc - Overview
- Hikma Pharmaceuticals Plc - Business segments
- Hikma Pharmaceuticals Plc - Key news
- Hikma Pharmaceuticals Plc - Key offerings
- Hikma Pharmaceuticals Plc - Segment focus
- SWOT
- Laboratorios Farmaceuticos ROVI - Overview
- Laboratorios Farmaceuticos ROVI - Business segments
- Laboratorios Farmaceuticos ROVI - Key offerings
- Laboratorios Farmaceuticos ROVI - Segment focus
- SWOT
- LEO Pharma AS - Overview
- LEO Pharma AS - Product / Service
- LEO Pharma AS - Key offerings
- SWOT
- NKF Pharma - Overview
- NKF Pharma - Product / Service
- NKF Pharma - Key offerings
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
- PharmaAction Ltd - Overview
- PharmaAction Ltd - Product / Service
- PharmaAction Ltd - Key offerings
- SWOT
- Yino Pharma Ltd - Overview
- Yino Pharma Ltd - Product / Service
- Yino Pharma Ltd - Key offerings
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Market Segmentation by Source
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Heparin Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Product Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Source Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Product - Market share 2025-2030 (%)
Exhibit 39: Data Table on Product - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Product
Exhibit 41: Data Table on Comparison by Product
Exhibit 42: Chart on Low-molecular-weight heparin - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Low-molecular-weight heparin - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Low-molecular-weight heparin - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Low-molecular-weight heparin - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Unfractionated heparin - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Unfractionated heparin - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Unfractionated heparin - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Unfractionated heparin - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Ultra-low-molecular-weight heparin - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Ultra-low-molecular-weight heparin - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Ultra-low-molecular-weight heparin - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Ultra-low-molecular-weight heparin - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Product ($ million)
Exhibit 55: Data Table on Market opportunity by Product ($ million)
Exhibit 56: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 57: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Route of Administration
Exhibit 59: Data Table on Comparison by Route of Administration
Exhibit 60: Chart on Subcutaneous injection - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Subcutaneous injection - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Subcutaneous injection - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Subcutaneous injection - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Intravenous infusion - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Intravenous infusion - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Intravenous infusion - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Intravenous infusion - Year-over-year growth 2025-2030 (%)
Exhibit 68: Market opportunity by Route of Administration ($ million)
Exhibit 69: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 70: Chart on Source - Market share 2025-2030 (%)
Exhibit 71: Data Table on Source - Market share 2025-2030 (%)
Exhibit 72: Chart on Comparison by Source
Exhibit 73: Data Table on Comparison by Source
Exhibit 74: Chart on Porcine - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Porcine - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Porcine - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Porcine - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Bovine - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Bovine - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Bovine - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Bovine - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Synthetic - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Synthetic - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Synthetic - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Synthetic - Year-over-year growth 2025-2030 (%)
Exhibit 86: Market opportunity by Source ($ million)
Exhibit 87: Data Table on Market opportunity by Source ($ million)
Exhibit 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 89: Chart on Market share by geography 2025-2030 (%)
Exhibit 90: Data Table on Market share by geography 2025-2030 (%)
Exhibit 91: Chart on Geographic comparison
Exhibit 92: Data Table on Geographic comparison
Exhibit 93: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 94: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 96: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 97: Chart on Regional Comparison - Europe
Exhibit 98: Data Table on Regional Comparison - Europe
Exhibit 99: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - North America
Exhibit 128: Data Table on Regional Comparison - North America
Exhibit 129: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Regional Comparison - Asia
Exhibit 146: Data Table on Regional Comparison - Asia
Exhibit 147: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 176: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 177: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 209: Market opportunity by geography ($ million)
Exhibit 210: Data Tables on Market opportunity by geography ($ million)
Exhibit 211: Impact of drivers and challenges in 2025 and 2030
Exhibit 212: Overview on criticality of inputs and factors of differentiation
Exhibit 213: Overview on factors of disruption
Exhibit 214: Impact of key risks on business
Exhibit 215: Companies covered
Exhibit 216: Company ranking index
Exhibit 217: Matrix on companies position and classification
Exhibit 218: Aspen Pharmacare Ltd. - Overview
Exhibit 219: Aspen Pharmacare Ltd. - Business segments
Exhibit 220: Aspen Pharmacare Ltd. - Key offerings
Exhibit 221: Aspen Pharmacare Ltd. - Segment focus
Exhibit 222: SWOT
Exhibit 223: B.Braun SE - Overview
Exhibit 224: B.Braun SE - Product / Service
Exhibit 225: B.Braun SE - Key offerings
Exhibit 226: SWOT
Exhibit 227: Baxter International Inc. - Overview
Exhibit 228: Baxter International Inc. - Business segments
Exhibit 229: Baxter International Inc. - Key offerings
Exhibit 230: Baxter International Inc. - Segment focus
Exhibit 231: SWOT
Exhibit 232: Bioiberica S.A.U. - Overview
Exhibit 233: Bioiberica S.A.U. - Product / Service
Exhibit 234: Bioiberica S.A.U. - Key offerings
Exhibit 235: SWOT
Exhibit 236: Celsus Laboratories Inc. - Overview
Exhibit 237: Celsus Laboratories Inc. - Product / Service
Exhibit 238: Celsus Laboratories Inc. - Key offerings
Exhibit 239: SWOT
Exhibit 240: CZ Pharma - Overview
Exhibit 241: CZ Pharma - Product / Service
Exhibit 242: CZ Pharma - Key offerings
Exhibit 243: SWOT
Exhibit 244: Gland Pharma Ltd - Overview
Exhibit 245: Gland Pharma Ltd - Product / Service
Exhibit 246: Gland Pharma Ltd - Key offerings
Exhibit 247: SWOT
Exhibit 248: Hepalink Group - Overview
Exhibit 249: Hepalink Group - Product / Service
Exhibit 250: Hepalink Group - Key offerings
Exhibit 251: SWOT
Exhibit 252: Hikma Pharmaceuticals Plc - Overview
Exhibit 253: Hikma Pharmaceuticals Plc - Business segments
Exhibit 254: Hikma Pharmaceuticals Plc - Key news
Exhibit 255: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 256: Hikma Pharmaceuticals Plc - Segment focus
Exhibit 257: SWOT
Exhibit 258: Laboratorios Farmaceuticos ROVI - Overview
Exhibit 259: Laboratorios Farmaceuticos ROVI - Business segments
Exhibit 260: Laboratorios Farmaceuticos ROVI - Key offerings
Exhibit 261: Laboratorios Farmaceuticos ROVI - Segment focus
Exhibit 262: SWOT
Exhibit 263: LEO Pharma AS - Overview
Exhibit 264: LEO Pharma AS - Product / Service
Exhibit 265: LEO Pharma AS - Key offerings
Exhibit 266: SWOT
Exhibit 267: NKF Pharma - Overview
Exhibit 268: NKF Pharma - Product / Service
Exhibit 269: NKF Pharma - Key offerings
Exhibit 270: SWOT
Exhibit 271: Pfizer Inc. - Overview
Exhibit 272: Pfizer Inc. - Business segments
Exhibit 273: Pfizer Inc. - Key news
Exhibit 274: Pfizer Inc. - Key offerings
Exhibit 275: Pfizer Inc. - Segment focus
Exhibit 276: SWOT
Exhibit 277: PharmaAction Ltd - Overview
Exhibit 278: PharmaAction Ltd - Product / Service
Exhibit 279: PharmaAction Ltd - Key offerings
Exhibit 280: SWOT
Exhibit 281: Yino Pharma Ltd - Overview
Exhibit 282: Yino Pharma Ltd - Product / Service
Exhibit 283: Yino Pharma Ltd - Key offerings
Exhibit 284: SWOT
Exhibit 285: Inclusions checklist
Exhibit 286: Exclusions checklist
Exhibit 287: Currency conversion rates for US$
Exhibit 288: Research methodology
Exhibit 289: Information sources
Exhibit 290: Data validation
Exhibit 291: Validation techniques employed for market sizing
Exhibit 292: Data synthesis
Exhibit 293: 360 degree market analysis
Exhibit 294: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Market Segmentation by Source
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Heparin Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Product Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Source Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Product - Market share 2025-2030 (%)
Exhibit 39: Data Table on Product - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Product
Exhibit 41: Data Table on Comparison by Product
Exhibit 42: Chart on Low-molecular-weight heparin - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Low-molecular-weight heparin - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Low-molecular-weight heparin - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Low-molecular-weight heparin - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Unfractionated heparin - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Unfractionated heparin - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Unfractionated heparin - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Unfractionated heparin - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Ultra-low-molecular-weight heparin - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Ultra-low-molecular-weight heparin - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Ultra-low-molecular-weight heparin - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Ultra-low-molecular-weight heparin - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Product ($ million)
Exhibit 55: Data Table on Market opportunity by Product ($ million)
Exhibit 56: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 57: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Route of Administration
Exhibit 59: Data Table on Comparison by Route of Administration
Exhibit 60: Chart on Subcutaneous injection - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Subcutaneous injection - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Subcutaneous injection - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Subcutaneous injection - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Intravenous infusion - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Intravenous infusion - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Intravenous infusion - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Intravenous infusion - Year-over-year growth 2025-2030 (%)
Exhibit 68: Market opportunity by Route of Administration ($ million)
Exhibit 69: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 70: Chart on Source - Market share 2025-2030 (%)
Exhibit 71: Data Table on Source - Market share 2025-2030 (%)
Exhibit 72: Chart on Comparison by Source
Exhibit 73: Data Table on Comparison by Source
Exhibit 74: Chart on Porcine - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Data Table on Porcine - Market size and forecast 2025-2030 ($ million)
Exhibit 76: Chart on Porcine - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Porcine - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Bovine - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Bovine - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Bovine - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Bovine - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Synthetic - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Synthetic - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Synthetic - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Synthetic - Year-over-year growth 2025-2030 (%)
Exhibit 86: Market opportunity by Source ($ million)
Exhibit 87: Data Table on Market opportunity by Source ($ million)
Exhibit 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 89: Chart on Market share by geography 2025-2030 (%)
Exhibit 90: Data Table on Market share by geography 2025-2030 (%)
Exhibit 91: Chart on Geographic comparison
Exhibit 92: Data Table on Geographic comparison
Exhibit 93: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 94: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 96: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 97: Chart on Regional Comparison - Europe
Exhibit 98: Data Table on Regional Comparison - Europe
Exhibit 99: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - North America
Exhibit 128: Data Table on Regional Comparison - North America
Exhibit 129: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Regional Comparison - Asia
Exhibit 146: Data Table on Regional Comparison - Asia
Exhibit 147: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 176: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 177: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 209: Market opportunity by geography ($ million)
Exhibit 210: Data Tables on Market opportunity by geography ($ million)
Exhibit 211: Impact of drivers and challenges in 2025 and 2030
Exhibit 212: Overview on criticality of inputs and factors of differentiation
Exhibit 213: Overview on factors of disruption
Exhibit 214: Impact of key risks on business
Exhibit 215: Companies covered
Exhibit 216: Company ranking index
Exhibit 217: Matrix on companies position and classification
Exhibit 218: Aspen Pharmacare Ltd. - Overview
Exhibit 219: Aspen Pharmacare Ltd. - Business segments
Exhibit 220: Aspen Pharmacare Ltd. - Key offerings
Exhibit 221: Aspen Pharmacare Ltd. - Segment focus
Exhibit 222: SWOT
Exhibit 223: B.Braun SE - Overview
Exhibit 224: B.Braun SE - Product / Service
Exhibit 225: B.Braun SE - Key offerings
Exhibit 226: SWOT
Exhibit 227: Baxter International Inc. - Overview
Exhibit 228: Baxter International Inc. - Business segments
Exhibit 229: Baxter International Inc. - Key offerings
Exhibit 230: Baxter International Inc. - Segment focus
Exhibit 231: SWOT
Exhibit 232: Bioiberica S.A.U. - Overview
Exhibit 233: Bioiberica S.A.U. - Product / Service
Exhibit 234: Bioiberica S.A.U. - Key offerings
Exhibit 235: SWOT
Exhibit 236: Celsus Laboratories Inc. - Overview
Exhibit 237: Celsus Laboratories Inc. - Product / Service
Exhibit 238: Celsus Laboratories Inc. - Key offerings
Exhibit 239: SWOT
Exhibit 240: CZ Pharma - Overview
Exhibit 241: CZ Pharma - Product / Service
Exhibit 242: CZ Pharma - Key offerings
Exhibit 243: SWOT
Exhibit 244: Gland Pharma Ltd - Overview
Exhibit 245: Gland Pharma Ltd - Product / Service
Exhibit 246: Gland Pharma Ltd - Key offerings
Exhibit 247: SWOT
Exhibit 248: Hepalink Group - Overview
Exhibit 249: Hepalink Group - Product / Service
Exhibit 250: Hepalink Group - Key offerings
Exhibit 251: SWOT
Exhibit 252: Hikma Pharmaceuticals Plc - Overview
Exhibit 253: Hikma Pharmaceuticals Plc - Business segments
Exhibit 254: Hikma Pharmaceuticals Plc - Key news
Exhibit 255: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 256: Hikma Pharmaceuticals Plc - Segment focus
Exhibit 257: SWOT
Exhibit 258: Laboratorios Farmaceuticos ROVI - Overview
Exhibit 259: Laboratorios Farmaceuticos ROVI - Business segments
Exhibit 260: Laboratorios Farmaceuticos ROVI - Key offerings
Exhibit 261: Laboratorios Farmaceuticos ROVI - Segment focus
Exhibit 262: SWOT
Exhibit 263: LEO Pharma AS - Overview
Exhibit 264: LEO Pharma AS - Product / Service
Exhibit 265: LEO Pharma AS - Key offerings
Exhibit 266: SWOT
Exhibit 267: NKF Pharma - Overview
Exhibit 268: NKF Pharma - Product / Service
Exhibit 269: NKF Pharma - Key offerings
Exhibit 270: SWOT
Exhibit 271: Pfizer Inc. - Overview
Exhibit 272: Pfizer Inc. - Business segments
Exhibit 273: Pfizer Inc. - Key news
Exhibit 274: Pfizer Inc. - Key offerings
Exhibit 275: Pfizer Inc. - Segment focus
Exhibit 276: SWOT
Exhibit 277: PharmaAction Ltd - Overview
Exhibit 278: PharmaAction Ltd - Product / Service
Exhibit 279: PharmaAction Ltd - Key offerings
Exhibit 280: SWOT
Exhibit 281: Yino Pharma Ltd - Overview
Exhibit 282: Yino Pharma Ltd - Product / Service
Exhibit 283: Yino Pharma Ltd - Key offerings
Exhibit 284: SWOT
Exhibit 285: Inclusions checklist
Exhibit 286: Exclusions checklist
Exhibit 287: Currency conversion rates for US$
Exhibit 288: Research methodology
Exhibit 289: Information sources
Exhibit 290: Data validation
Exhibit 291: Validation techniques employed for market sizing
Exhibit 292: Data synthesis
Exhibit 293: 360 degree market analysis
Exhibit 294: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global heparin market: Aspen Pharmacare Ltd., B.Braun SE, Baxter International Inc., Bioiberica S.A.U., Celsus Laboratories Inc., CZ Pharma, Fresenius Kabi AG, Gland Pharma Ltd, Hepalink Group, Hikma Pharmaceuticals Plc, Laboratorios Farmaceuticos ROVI, LEO Pharma AS, NKF Pharma, Opocrin S.p.A., Pfizer Inc., PharmaAction Ltd, Sagent Pharmaceuticals Inc., Syntexa Pharmaceuticals Inc., TRENDING PHARMACEUTICALS, Yino Pharma Ltd.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing research and development activities and new therapeutic applications of heparin."
According to the report, one of the major drivers for this market is the increasing prevalence of coagulation disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aspen Pharmacare Ltd.
- B.Braun SE
- Baxter International Inc.
- Bioiberica S.A.U.
- Celsus Laboratories Inc.
- CZ Pharma
- Fresenius Kabi AG
- Gland Pharma Ltd
- Hepalink Group
- Hikma Pharmaceuticals Plc
- Laboratorios Farmaceuticos ROVI
- LEO Pharma AS
- NKF Pharma
- Opocrin S.p.A.
- Pfizer Inc.
- PharmaAction Ltd
- Sagent Pharmaceuticals Inc.
- Syntexa Pharmaceuticals Inc.
- TRENDING PHARMACEUTICALS
- Yino Pharma Ltd
